Access cutting-edge cancer treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access cancer specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab or docetaxel in participants with advanced solid tumors. This study is a first-in-human (FIH) study of BMS-986340 in participants with advanced solid tumors.
Sponsor: Bristol-Myers Squibb
Check if you qualify for this cancer clinical trial in Portland, OR
If you're searching for cancer treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.